M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Medicofarma Biotech SA
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medicofarma Biotech SA
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicofarma Biotech SA
WSE:MDB
Total Equity
zł12.6m
CAGR 3-Years
N/A
CAGR 5-Years
65%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Total Equity
zł2.8m
CAGR 3-Years
-31%
CAGR 5-Years
3%
CAGR 10-Years
16%
R
Ryvu Therapeutics SA
WSE:RVU
Total Equity
zł177.8m
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
37%
S
Selvita SA
WSE:SLV
Total Equity
zł316.1m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medicofarma Biotech SA
Glance View

Market Cap
25.6m PLN
Industry
Life Sciences Tools & Services

Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

MDB Intrinsic Value
0.096 PLN
Overvaluation 75%
Intrinsic Value
Price
M

See Also

What is Medicofarma Biotech SA's Total Equity?
Total Equity
12.6m PLN

Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's Total Equity amounts to 12.6m PLN.

What is Medicofarma Biotech SA's Total Equity growth rate?
Total Equity CAGR 5Y
65%

Over the last year, the Total Equity growth was 0%.

Back to Top